TherapeuticsMD, Inc. (NASDAQ:TXMD) Short Interest Update

TherapeuticsMD, Inc. (NASDAQ:TXMD) was the target of a large drop in short interest in the month of January. As of January 15th, there was short interest totalling 12,000 shares, a drop of 43.7% from the December 31st total of 21,300 shares. Currently, 0.1% of the company’s stock are short sold. Based on an average daily volume of 275,000 shares, the days-to-cover ratio is presently 0.0 days.

TherapeuticsMD Price Performance

NASDAQ TXMD traded down $0.01 during trading hours on Friday, hitting $1.07. The company’s stock had a trading volume of 11,061 shares, compared to its average volume of 854,252. TherapeuticsMD has a 52 week low of $0.70 and a 52 week high of $2.75. The company’s 50-day simple moving average is $1.18 and its two-hundred day simple moving average is $1.49.

TherapeuticsMD (NASDAQ:TXMD) last posted its earnings results on Tuesday, November 12th. The company reported ($0.05) earnings per share for the quarter. The company had revenue of $0.55 million during the quarter. TherapeuticsMD had a negative net margin of 207.77% and a negative return on equity of 14.08%.

Wall Street Analyst Weigh In

Separately, StockNews.com began coverage on shares of TherapeuticsMD in a report on Tuesday, January 14th. They set a “hold” rating on the stock.

About TherapeuticsMD

TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.